SCHEMBL17655321

SCHEMBL17655321

CSOc1ccc(O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ESR1 P03372 1/20 0.50
LTA4H P09960 5/20 0.46
NR1H2 P55055 2/20 0.42
BAX Q07812 1/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
CA12 O43570 1/20 0.42
GMNN O75496 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
LMNA P02545 1/20 0.42
CA3 P07451 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
TYR P14679 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19774489 0.85 ESR2 (0.61) ESR2MEN1KMT2AESR1LTA4H
SCHEMBL11764231 0.76 ESR2 (0.52) ESR2MEN1KMT2AESR1LTA4H
SCHEMBL27371981 0.76 CA1 (0.61) ESR2MEN1KMT2ALTA4HKDM4E
SCHEMBL16422185 0.76 ACHE (0.50) MEN1KMT2AALDH1A1CA1CA2
SCHEMBL27729163 0.74 CYP2A6 (0.42) MEN1KMT2AKDM4ENPC1ALDH1A1
SCHEMBL27971125 0.74 LMNA (0.42) MEN1KMT2AKDM4ENPC1ALDH1A1
SCHEMBL20112487 0.74 TDP1 (0.52) MEN1KMT2ANPC1ALDH1A1CYP3A4
SCHEMBL23735063 0.73 CA2 (0.58) KDM4ECA1CA2CA4CA5A
SCHEMBL27986636 0.72 NR1H2 (0.35) NR1H2
SCHEMBL8154525 0.72 CA1 (0.59) KMT2AKDM4ENPC1ALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760775-B2 Steroids and protein-conjugates thereof REGENERON PHARMACEUTICALS, INC. 2023-09-19 US disclosed
US-20210040144-A1 STEROIDS AND PROTEIN-CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. 2021-02-11 US disclosed
US-10711032-B2 Steroids and protein-conjugates thereof REGENERON PHARMACEUTICALS, INC. (US) 2020-07-14 US disclosed
US-20180155389-A1 STEROIDS AND PROTEIN-CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. 2018-06-07 US disclosed
EP-2778201-B1 COLOURED COMPOSITION AND INK FOR INKJET RECORDING FUJIFILM CORP (JP) 2016-04-06 EP disclosed
CN-105473584-A Thiophene- or furan-substituted isothiazoline compounds as pesticides MERIAL LTD 2016-04-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180155389-A1 STEROIDS AND PROTEIN-CONJUGATES THEREOF SERPINA6, NR3C1, NR3C2 ESR2 171/4885MEN1 2876/4885KMT2A 4571/4885
US-10711032-B2 Steroids and protein-conjugates thereof SERPINA6, NR3C1, NR3C2 ESR2 171/4885MEN1 2876/4885KMT2A 4571/4885
US-20210040144-A1 STEROIDS AND PROTEIN-CONJUGATES THEREOF SERPINA6, NR3C1, NR3C2 ESR2 155/4885MEN1 2791/4885KMT2A 4548/4885
US-11760775-B2 Steroids and protein-conjugates thereof SERPINA6, NR3C1, NR3C2 ESR2 155/4885MEN1 2791/4885KMT2A 4548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.